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Aim: To create a new scoring system for femoral pseudoaneurysm (FPA) formation after diagnostic or interventional cardiac
catheterization.
Materials and methods: We evaluated 41,322 transfemoral catheterization procedures performed in our center within 7 years. Among
all procedures, 630 FPAs developed that required surgical repair. Eighty-five cases were managed by compression with duplex guidance.
As a case-control group, 1260 patients were selected from the patients who had been catheterized during the same time period but did
not develop FPA. We created the risk scoring system according to body mass index, hypertension, diabetes mellitus, catheter diameter,
coronary artery disease, atherosclerosis, and number of patients treated per day in a particular room.
Results: FPA required operative repair in 1.1% of patients who underwent cardiac catheterization for diagnosis and in 4.7% of cardiac
interventional procedures. We determined that if the risk score is greater than 15, the probability of formation of a FPA is 7 times greater
than normal.
Conclusion: This study confirms that FPA is a morbid situation, and high risk scores are important because FPA formation is 7 times
greater than normal. This novel method of calculating risk score allows for the stratification of patients into 4 levels of risk.
Key words: Femoral pseudoaneurysm, femoral catheterization, risk scoring

1. Introduction
Pseudoaneurysms are pulsatile masses that connect with
arterial lumen, destroying the wall entirely. Pulsatile
mass, palpable thrill, and audible to-and-fro murmur are
characteristics for the diagnosis of pseudoaneurysms (1).
Vascular complications at the puncture site represent an
ongoing hazard of percutaneous coronary and peripheral
vascular catheterizations. Although many complications
remain minor and can be corrected conservatively or with
minimal surgery under local anesthesia, these treatments
extend the length of hospitalization, the cost of the
underlying catheter procedure, and patient discomfort.
Femoral pseudoaneurysm (FPA) occurs in 0.1%
to 0.2% of diagnostic angiograms and 0.8% to 2.2% of
cases following interventional procedures (2). With
more than 1 million cardiac catheterizations being
performed in the United States each year, postprocedure
pseudoaneurysm is a relatively rare occurrence. The
incidence of this complication has recently increased
* Correspondence: drmates@yahoo.com

with the more frequent use of thrombolytic antiplatelet
agents and anticoagulants, and larger-sized cannulae for
interventional procedures (3). FPAs are usually caused by
punctures of the femoral artery that are too distal, at the
level of bifurcation of the femoral artery or below (4). With
the advancement of technology in intravascular catheters
and increased experience of physicians, the number of
angiographic and interventional procedures increases
progressively. However, local vascular complications
of percutaneous procedures such as bleeding, vessel
thrombosis, emboli, dissection, and arteriovenous
fistulae present significant clinical problems following
catheterization procedures. FPA constitutes the most
common of these complications, reported to have an
incidence of 0.2%–2% (5). In predicting patients at high
risk for FPA, more rigorous measures can be taken for
the prevention of this complication. In this way, the
number of rehospitalizations and surgical interventions
can be reduced.
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We previously reported the correlation between
FPA formation and risk factors of body mass index,
hypertension, diabetes mellitus, catheter diameter,
coronary artery disease, atherosclerosis, and number of
patients treated per day in a particular room (6). Here,
we want to introduce a new risk scoring system for FPA
formation with these factors.
2. Materials and methods
Between 1 January 1997 and 31 December 2003 at
our center, 36,218 diagnostic and 5104 interventional
catheterization procedures (total = 41,322) for cardiac
disease were performed via the femoral artery, and 630 of
these patients required surgical repair for FPA formation.
During this time, 85 of the small FPA cases could be
managed by compression therapy with duplex guidance.
These nonsurgical cases were not included in the study. As
a case-control group, 1260 patients were selected randomly
from the patients who had been catheterized in our
institute during the same time. Two control patients were
selected for each FPA case. The study and control patients
were matched according to age, sex, and catheterization
day. Body mass index (BMI), hypertension (HT), diabetes
mellitus (DM), coronary artery disease (CAD), catheter
diameter, antiaggregant therapy, and the number of
patients treated per day in a particular room were evaluated
retrospectively as risk factors. P and R values and odds
ratios were calculated for each of the 7 parameters The
results were rounded and used to construct the risk score
index of each parameter. The risk scores of each parameter
with respect to their odds ratios are presented in Table 1,
and the scores for BMI (≥28), daily number of patients in a
particular room (≥18), catheter number (≥7), presence of

CAD, presence of DM, presence of HT, and use clopidogrel
were 2, 2, 5, 1, 1, 2, and 7, respectively.
Considering the total risk score as 20, we defined 4 risk
groups based on gradation of risk values as follows: values
1 through 5 were considered minimal risk, 5–10 moderate
risk, 10–15 high risk, and above 15 severe risk. Referencing
this scoring system, scores of the control and study groups
were evaluated and their respective percentile ratios were
derived.
BMI was calculated using this formula: BMI (kg⁄m2)
= weight⁄(height2). The procedures were performed by 30
different cardiologists, who treated 250 to 300 patients
per year, in 4 catheterization laboratories in our center.
Catheter diameters ranged from 6 F to 8 F. For definite
diagnosis and location of the neck, size, and depth of the
FPA, a complete vascular examination was performed
by color-flow duplex ultrasonography (ATL 3500; HDI,
Milwaukee, WI, USA) using a linear probe (5–7.5 MHz).
Color-flow Doppler was used to determine the flow
into the FPA and was also used for determination of
occlusions by detecting the diminishment of the color
saturations. The volume of the FPA was calculated with
the formula FPA = (width × length × height) × 0.52. All
dimensions were measured from the outermost border of
the FPA neck. Neck size and length were also determined.
Patients with FPAs of 5 cm2 or smaller and neck lengths
of 8 mm or longer underwent duplex ultrasound-guided
compression (n = 85), and all others underwent surgical
repair (n = 630).
For the diagnostic angiography procedures, we did
not use any anticoagulant or antiplatelet agents. For
interventional procedures, 10,000 U of heparin was given
by intravenous bolus, followed by 5000 U/h to keep the

Table 1. Independent risk factors in femoral pseudoaneurysm formation.
Variable

Study group (n = 630)

Control group (n = 1260)

P-value

Odds ratio

BMI (kg/m2)

28.69 ± 3.33

24.85 ± 3.12

0.001

2.220 (≥28)

Daily patients in a particular room

18.1 ± 2.8

16.1 ± 2.5

0.001

1.852 (≥18)

6 F catheter

390 (61.9%)

858 (68.1%)

0.001

5.132 (≥7)

CAD

410 (65.0%)

712 (56.5%)

0.022

1.025

DM

280 (44.4%)

453 (35.9%)

0.039

1.125

HT

390 (61.9%)

712 (56.5%)

0.011

1.825

Use of clopidogrel

232 (36.8%)

178 (14.2%)

0.001

7.121

BMI: body mass index, CAD: coronary artery disease, DM: diabetes mellitus, HT: hypertension.
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3. Results
The mean procedure times (interval between sheath
insertion and the end of the procedure) for diagnostic
angiography and interventional catheterization were 16 ± 6
min and 37 ± 12 min, respectively. Two patients with FPAs
died during operation and during the early hospitalization
period. In both cases, FPA was repaired concomitantly with
coronary artery bypass grafting surgery. The time from
the puncture of the femoral artery to FPA diagnosis was
2.1 ± 0.7 days. During FPA repair, 72 patients underwent
concomitant femoral embolectomy, and in 83 patients
FPA was repaired during coronary artery bypass grafting.
Our incidence of FPAs that required surgical repair was
1.1% in diagnostic procedures and 4.7% in interventional
procedures. Our overall FPA rate was 1.5%.
Between the evaluated risk factors, the highest
risk factor for the development of FPA was the use of
clopidogrel. Development of FPA was observed to have
a 7-fold increase in patients taking clopidogrel. Similarly,
using 7 F catheters will increase the FPA risk 5-fold. BMI
over 28, more patients seen daily in a particular room,
DM, presence of HT, and presence of CAD will also cause
increases in the development of FPA at different rates.
Percent ratios of risk scoring groups and statistical
results for the control and study groups are shown in Table
2 and the Figure.

% ratio

activating clotting time between 250 and 300 s. We used
clopidogrel (Plavix; Bristol-Myers Squibb, New York, NY,
USA) as a single dose of 300 g 6 h before the procedures
and continued the clopidogrel at 75 mg/day after the
procedures. In diagnostic catheterization procedures,
our routine postprocedure hemostasis protocol is
manual compression for approximately 20 min and then
mechanical compression by sandbag for approximately
2 h. Patients are kept on bed rest for approximately 6 h.
Cardiology residents or physician assistants perform this
compression. In interventional catheterization procedures,
we stabilize the introducer by suturing it to the skin for 6
h, after which we remove the introducer and then apply
the same compression as for diagnostic catheterization.
All patients who undergo interventional catheterization
are observed for at least 1 night in the hospital.
Inclusion criteria for surgical therapy of FPA were
rapid expansion of the site of puncture at the groin area,
increased skin pressure (tenderness), marked pain,
hypotension, pulsatile hematoma, a new thrill or bruit,
concomitant distal ischemia or neurological deficit due
to local pressure, and a short, noncompressible neck (<8
mm) on Doppler ultrasonography. An FPA volume of
more than 5 cm2 in other patients who did not fulfill these
criteria was treated conservatively. Eighty-five patients
who had a compressible neck and a mass volume of 5 cm2
or less were managed conservatively without operation.
Statistical analyses were performed using SPSS 11
(SPSS Inc., Chicago, IL, USA). Data were analyzed with the
Pearson test for numeric variables and the Spearman test
for nonparametric variables. Stepwise backward logistic
multivariate regression analysis was applied to analyze
associations between risk factors and FPA formation. Age
and sex were added to these parameters to check for good
matching. All values were expressed as mean ± standard
deviation. P < 0.05 was considered to be statistically
significant.
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Figure. Graphical view of scoring system.
pseudoaneurysm.

FPA: femoral

Table 2. Scoring system and percent ratios.
Score

Study group
(n = 630)

Control group
(n = 1260)

Study group
(% ratio)

Control group
(% ratio)

P-value

1–5

26

441

4

35

<0.001

5–10

96

391

15

31

<0.001

10–15

223

331

35

26

<0.001

15–20

285

97

45

8

<0.001
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4. Discussion
There are many risk scoring systems in cardiac surgery (7,8)
designed according to patient characteristics and focused
on mortality and morbidity. We designed a new scoring
system for FPA formation according to independent risk
factors that had been previously found. The incidence
of FPA has increased dramatically in recent years and is
estimated at 0.5% for diagnostic procedures; it may increase
to 9% or more for therapeutic procedures. This increasing
incidence is associated with the increased number of
arterial punctures performed for diagnostic or therapeutic
purposes and with their complexity and duration.
There are many risk factors for FPA. It has been
reported that anticoagulation or antiplatelet therapy
before catheterization speeds pseudoaneurysm formation.
Other risk factors for the development of FPA are age older
than 60 years, female sex, catheter size greater than 7 F,
and concurrent anticoagulation (9). We created our new
scoring system for FPA from these risk factors and we are
using this scoring system. We think that this scoring system
is basic and easily used. If the risk score is greater than 15,
the probability of formation of FPA is 7 times greater than
normal. If a patient has a score above 15, cardiologists are
informed and operate with care.

Risk stratification will inform patients and clinicians
of the likely risk of FPA. The use of antiplatelet agents
stands out as the biggest risk factor. The second most
important risk factor is the use of catheters with larger
diameters. Proper selection of smaller catheter diameters
for patients will reduce this risk. The complication rate was
increased in parallel with the faster circulation of patients
in a particular room. In addition, controlling HT can
reduce FPA complications. We suggest that applying more
meticulous compression for patients with risk factors
might significantly decrease FPA. Therefore, proper and
optimal local compression should be crucial in day-today practice for busy interventionists, whatever the cost.
To show the importance of compression for decreasing
FPA complications, further controlled studies should be
initiated. Cardiologists may use this scoring system for
FPAs, and this scoring system will be improved in the
future.
This study confirms that femoral pseudoaneurysm is
a morbid situation, that a high risk score is important
because FPA formation is 7 times greater than normal
in such cases, and that a novel calculating of risk scores
allows for the stratification of patients into 4 levels of
risk.
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